Catalyst

Slingshot members are tracking this event:

ADRO Gastrointestinal cancer treatment pLADD to be evaluated in Aduro phase 1 trial, which will begin in first half of 2017

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
ADRO Community voting in process
Slingshot Insights Explained
Catalyst Date
Occurred on:
Sep 27, 2017
Occurred Source:
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Gastrointestinal Cancer, Pladd, Phase 1